S

Senti Biosciences
D

SNTI

2.27000
USD
0.02
(0.89%)
مغلق
حجم التداول
70
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
10,394,282
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Senti Biosciences Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.